'

Dupont Q3 2015 Earnings Report

Понравилась презентация – покажи это...





Слайд 0

DuPont Third-Quarter 2015 Earnings Conference Call October 27, 2015


Слайд 1

Regulation G The attached charts include company information that does not conform to generally accepted accounting principles (GAAP). Management believes that an analysis of this data is meaningful to investors because it provides insight with respect to ongoing operating results of the company. These measures should not be viewed as an alternative to GAAP measures of performance. Furthermore, these measures may not be consistent with similar measures provided by other companies. This data should be read in conjunction with previously published company reports on Forms 10-K, 10-Q, and 8-K. These reports, along with reconciliations of non-GAAP measures to GAAP are available on the Investor Center of www.dupont.com under Filings and Reports – Reconciliations and Other Data. Reconciliations of non-GAAP measures to GAAP are also included with this presentation. Forward-Looking Statements This document contains forward-looking statements which may be identified by their use of words like “plans,” “expects,” “will,” “believes,” “intends,” “estimates,” “anticipates” or other words of similar meaning. All statements that address expectations or projections about the future, including statements about the company’s strategy for growth, product development, regulatory approval, market position, anticipated benefits of recent acquisitions, timing of anticipated benefits from restructuring actions, outcome of contingencies, such as litigation and environmental matters, expenditures and financial results, are forward looking statements. Forward-looking statements are not guarantees of future performance and are based on certain assumptions and expectations of future events which may not be realized. Forward-looking statements also involve risks and uncertainties, many of which are beyond the company’s control. Some of the important factors that could cause the company’s actual results to differ materially from those projected in any such forward-looking statements are: fluctuations in energy and raw material prices; failure to develop and market new products and optimally manage product life cycles; ability to respond to market acceptance, rules, regulations and policies affecting products based on biotechnology; significant litigation and environmental matters; failure to appropriately manage process safety and product stewardship issues; changes in laws and regulations or political conditions; global economic and capital markets conditions, such as inflation, interest and currency exchange rates; business or supply disruptions; security threats, such as acts of sabotage, terrorism or war, weather events and natural disasters; ability to protect and enforce the company’s intellectual property rights; successful integration of acquired businesses and separation of underperforming or nonstrategic assets or businesses, including timely realization of the expected benefits from the separation of Performance Chemicals. The company undertakes no duty to update any forward-looking statements as a result of future developments or new information. Developing Markets Total developing markets is comprised of Developing Asia, Developing Europe, Middle East & Africa, and Latin America. A detailed list of all developing countries is available on the Earnings News Release link on the Investor Center website at www.dupont.com. 1


Слайд 2

3Q and YTD 2015 Financial Results $ in millions, except EPS 3Q15 vs. 3Q14 YTD15 vs. YTD14 EPS Operating earnings* Operating earnings, ex currency* GAAP earnings $0.13 (67%) $2.49 (11%) $0.30 (23%) $3.02 8% $0.14 (61%) $2.33 (16%) 3Q15 Consolidated Net Sales $4,873 vs. 3Q14 (17%) YTD15 $19,831 YTD14 (12%) Currency Impact (8%) (7%) Portfolio (1%) (2%) Local Price & Product Mix (1%) - Volume (7%) (3%) Segment Operating Earnings* $433 (37%) $3,690 (13%) * See appendix for reconciliations of Non-GAAP measures 2


Слайд 3

3Q 2015 Operating EPS* Variance $0.06 ($0.02) ($0.08) ($0.22) $0.39 Currency ($0.17) Operating EPS* $0.13 Operating EPS* 3Q14 Corp Exp & Int EGL Tax Rate Segment Results 3Q15 Key Factors  Lower corporate expense and interest contributed $0.06 per share to operating earnings on disciplined cost savings and continued productivity  Net after-tax exchange gains (losses) were a $0.02 per share headwind in the quarter  A higher tax rate as a result of a shift in geographic mix of earnings negatively impacted results by $0.08 per share  Segment results, including a $0.17 per share impact from currency, declined due to continued challenging agriculture markets * See appendix for details of significant items and reconciliation of Non-GAAP measures 3


Слайд 4

Global Net Sales – Regional Highlights 3Q 2015 Net Sales by Region Latin America 16% Developed Asia 10% Developing Asia 17% U.S. & Canada 32% Developing EMEA 8% Developed EMEA 17% 3Q 2014 Net Sales by Region U.S. & Canada 29% Latin America 20% Developing EMEA 7% Developed Asia 10% Developing Asia 16% Developed EMEA 18%  Shifts mainly reflect the impact of currency movements, particularly the Brazilian Real versus the U.S. Dollar, and weakness in Agriculture markets 4


Слайд 5

3Q 2015 Segment Operating Earnings* Variance ($ in millions) $14 $10 $3 ($38) ($39) ($49) ($154) $686 Segment Operating Earnings* $433 Segment Operating Earnings* 3Q14 E&C IB N&H Other S&P Perf Mat Ag 3Q15 Key Factors  Electronics & Communications earnings up on cost reductions, continued productivity and demand for Tedlar ® film and consumer electronics, partially offset by competitive pressures on Solamet ® paste  Industrial Biosciences results driven by volume growth and benefits from cost reductions and productivity, partially offset by lower price and currency  Other reflects increased costs associated with discontinued businesses, primarily environmental costs  Cost reductions, continued productivity and volume growth in medical packaging in Safety & Protection were more than offset by lower demand from the oil and gas industry and delays in military spending, the impact of currency, and portfolio  Cost reductions and continued productivity in Performance Materials were more than offset by negative currency impact and lower ethylene price and volume  Improved productivity, cost reductions and pricing gains in Agriculture were more than offset by the negative impact of currency and decreased volumes due to lower seed sales, reduced demand for insect control products, and the impact of the LaPorte facility shutdown * See appendix for details of significant items and reconciliation of Non-GAAP Measures 5


Слайд 6

Balance Sheet and Cash September 30, 2015 Free Cash Flow* Free Cash Flow • About even with prior year YTD 14 • Reflects expected seasonal working capital outflows • $6.2B net debt** 0.0 $ Billions Balance Sheet -1.0 -2.0 -3.0 -4.0 • $2 billion share repurchase launched • 29 million shares retired, representing 80 percent of expected total; program to be completed in 4Q Cash and Debt 16 Expected Uses of Cash for Remainder of 2015 • Continued growth investments in line with strategy Gross Debt Cash Net Debt** 12 $ Billions • Capex spend est. $1.5B for FY 2015 YTD 15 8 4 0 Mar-14 Jun-14 Sep-14 Dec-14 Mar-15 Jun-15 Sep-15 * Free Cash Flow is cash used for operating activities of ($1,845MM) and ($1,802MM) less purchases of plant, property and equipment of $1,291MM and $1,311MM for the nine-months ended September 30, 2015, and 2014, respectively. ** See appendix for reconciliation of Non-GAAP measures. 6


Слайд 7

Other Highlights • Redesign initiative on track, contributed incremental $0.10 per share to operating earnings in the quarter; on track to deliver ~$0.40 per share in incremental savings for full year 2015, in addition to the $0.07 per share realized last year • Accelerated annual run rate cost savings of $1.3 billion to year-end 2016 from 2017 • Increased targeted savings under operational redesign to $1.6 billion run-rate by end of 2017 • $2 billion accelerated share repurchase program launched in the quarter; program to be completed in 4Q • On October 22nd, DuPont announced its fourth quarter 2015 dividend of $0.38 per share 7


Слайд 8

Full Year 2015 Expectations and Outlook • Net sales down about 11 - 12 percent versus prior year due to impact of currency, challenging agriculture environment and portfolio changes • Operating EPS* about $2.75 per share • Includes currency headwind of $0.72 per share • Base tax rate 22% • Unfavorable versus prior year due to anticipated geographic mix of earnings • Includes assumption of re-enactment of U.S. tax extenders * See appendix for reconciliation of Non-GAAP measures 8


Слайд 9

Electronics & Communications 3Q Sales Vol -7%, Local Price -5%, Currency -2%, Port./Other 0% 3Q Comments $ in Millions 650 • Sales – Down 14 percent as volume growth in Tedlar® film in photovoltaics and products used in consumer electronics applications was more than offset by the impact of competitive pressures on sales of Solamet® paste, lower metals pricing and the negative impact of currency 600 550 620 • Operating Earnings – Improved 16 percent to $104 million as cost reductions and continued productivity more than offset sales declines 532 500 450 3Q14 Volume Local Price 3Q15 (ex-curr & portf.) Curr. Portf./ Other 3Q15 4Q Outlook 3Q Operating Earnings* • PV market demand remains strong; consumer electronics markets slowing 15% 75 10% 50 5% 25 0 0% 3Q13 3Q14 * See appendix for reconciliation of non-GAAP measures. 3Q15 Margin 20% 100 $ in Millions 125 • Sales – Down low-teens percent with continued solid demand for Tedlar® film more than offset by lower Solamet® paste sales, the negative impact of metals pricing and currency • Operating Earnings – Down mid-teens percent as continued productivity is expected to be more than offset by the impact of lower sales • Continuing to advance our Solamet® paste offering with a new product launch targeted for next year 9


Слайд 10

Industrial Biosciences 3Q Sales 3Q Comments • Sales – Down 3 percent as 7 percent volume growth was more than offset by the impact of currency and lower prices, primarily for biomaterials. Vol 7%, Local Price -4%, Currency -6%, Port./Other 0% $ in Millions 350 • Volume improved across the business, driven primarily by health and personal care and food market demand. 325 300 314 • Operating Earnings – Up 24 percent as volume growth, cost reductions and continued productivity were partially offset by lower prices and a $3 million negative impact from currency. Excluding currency, earnings would have increased 31 percent. 305 275 250 3Q14 Volume Local Price 3Q15 (ex-curr & portf.) Curr. Portf./ Other • Operating margins expanded 360 bps in the quarter 3Q15 4Q Outlook 3Q Operating Earnings* 60 20.0% 50 15.0% 40 30 10.0% 20 5.0% 10 0 Margin $ in Millions • Anticipate higher volumes will be offset by the negative impact of currency and lower price resulting in Sales down mid-single digit percent. • Operating Earnings – Up about mid-teens percent versus prior year on higher volumes and continued productivity. • Bioactives volumes expected to benefit from new product offerings and emerging market growth. 0.0% 3Q13 3Q14 3Q15 *See appendix for reconciliation of non-GAAP measures. 10


Слайд 11

Nutrition & Health 3Q Sales 3Q Comments Vol 0%, Local Price 0%, Currency-9%, Port./Other -1% $ in Millions 950 • Sales – 10 percent lower primarily due to a 9 percent negative impact from currency 900 • Strong growth in probiotics, ingredient systems and texturants was offset by competitive challenges in specialty proteins 850 • Operating Earnings – Increased $3 million as cost reductions and continued productivity more than offset $17 million of negative currency; up about 20 percent excluding the impact of currency 899 800 810 • Continued improvement in operating margin (+160 bps); nine consecutive quarters of year-over-year improvement 750 3Q14 Volume Local Price 3Q15 (ex-curr & portf.) Curr. Portf./ Other 3Q15 4Q Outlook 3Q Operating Earnings* • Market conditions to remain challenging • Continued momentum in probiotics, cultures, ingredient systems and texturants; specialty protein market to remain competitive 120 12% 80 9% 60 6% 40 3% 20 0 0% 3Q13 3Q14 3Q15 Margin $ in Millions 100 • Sales – Expected to be low-single digits percent lower with volume growth more than offset by strong currency headwinds • Operating Earnings – Expected to be up high-single digits percent with volume growth and continued productivity partially offset by the absence of a $18 million gain on termination of a distribution agreement in the prior year and the negative impact of currency *See appendix for reconciliation of non-GAAP measures. 11


Слайд 12

Safety & Protection Protection Technologies (DPT), Building Innovations (BI), Sustainable Solutions (DSS) 3Q Comments 3Q Sales • Sales – Down 15 percent, driven by softness in volume, currency and portfolio changes • Increased demand for medical packaging was more than offset by weakness in Nomex® thermal apparel and Sustainable Solutions offerings for the oil and gas industry and Kevlar® high strength material from military spending delays • Operating Earnings – Down 20 percent as the benefits of cost reductions and productivity improvements were more than offset by the portfolio impact of the Sontara® divestiture, lower volume, higher costs and a $13 million negative currency impact; excluding currency, earnings down about 13 percent • Slower than expected recovery after the 1Q Chamber Works’ outage increased unit costs in 3Q Vol -6%, Local Price -1%, Currency-4%, Port./Other -4% $ in Millions 1000 950 900 976 850 831 800 750 3Q14 Volume Local Price 3Q15 (ex-curr & portf.) Curr. Portf./ Other 3Q15 3Q Operating Earnings* 4Q Outlook 15% 100 10% 50 5% 0 Margin 20% 150 • Sales – Volume growth across all businesses is expected to be offset by currency, resulting in sales about even with prior year 25% 200 $ in Millions 250 • Operating Earnings – Even with prior year as cost reductions and continued productivity will be offset by currency 0% 3Q13 3Q14 3Q15 *See appendix for reconciliation of non-GAAP measures. 12


Слайд 13

Performance Materials Performance Polymers (DPP), Packaging & Industrial Polymers (P&IP) 3Q Comments • Sales – Down 15 percent on negative currency impact and lower ethylene prices and volume; Currency and portfolio reduced sales by 7 percent 3Q Sales Vol -3%, Local Price -5%, Currency -6%, Port./Other -1% • Lower ethylene prices and volumes and reductions in Asia Pacific auto builds driving year over year sales decline 1500 $ in Millions 1600 • Average ethylene spot prices down 60 percent year over year • Operating Earnings – Down 13 percent as cost reductions and continued productivity was more than offset by $47 million of negative currency impact and lower ethylene prices and volume; excluding currency, earnings about even with prior year • Operating earnings included a $16 million net benefit from a joint venture, which was more than offset by the absence of a prior year $23 million gain on the sale of a majority interest in a joint venture. 1400 1,531 1300 1,302 1200 3Q14 Volume Local Price 3Q15 (ex-curr & portf.) Curr. Portf./ Other 3Q15 4Q Outlook 3Q Operating Earnings* 320 24% 240 18% 160 12% 6% 0 3Q13 3Q14 3Q15 Margin 30% 80 $ in Millions 400 • Sales – Down high-single digits percent as volume growth will be more than offset by currency and lower ethylene prices • Operating Earnings – Down high-teens percent as higher volumes and lower product costs are more than offset by the impact of currency and lower ethylene prices • Lower raw material costs expected to provide a favorable impact, partially offset by lower ethylene prices 0% *See appendix for reconciliation of non-GAAP measures. 13


Слайд 14

Agriculture Pioneer, Crop Protection 3Q Sales 3Q Comments • Sales – 30 percent lower as higher local crop protection prices were more than offset by 17 percent lower volumes and a 15 percent negative currency impact • Volume declined due to lower corn seed volumes as growers are expected to reduce corn planted area in Brazil, reduced demand for insect control products in Brazil reflecting low expected insect pressure and the impact of the shutdown of the LaPorte manufacturing facility, and lower soybean seed volumes • 1600 Demand for seed and crop protection products, primarily in Brazil, further weakened in the quarter impacted by macroeconomic and competitive pressures • Vol -17%, Local Price 3%, Currency -15%, Port./Other -1% Operating Earnings – Decreased $154 million as cost reductions and continued productivity, increases in local price, $27 million in gains from asset sales and a $21 million benefit related to prior periods were more than offset by lower volumes, $108 million negative currency impact and about a $40 million negative impact from the LaPorte shutdown $ in Millions 1500 1400 1300 1,563 1200 1100 1000 1,093 900 3Q14 Volume Local Price 3Q15 (ex-curr & portf.) Curr. Portf./ Other 3Q15 4Q Outlook 3Q Operating Earnings* Expect strong headwinds from macroeconomic and competitive pressures to continue in 4Q 0.0% • Limited launch of Leptra® corn hybrids for upcoming Brazil Safrinha season -50 -5.0% • -100 -10.0% Sales – Down low-teens percent as local pricing gains are expected to be more than offset by currency, lower crop protection volumes in Brazil and the continued impact of the shutdown of LaPorte -150 -15.0% • -200 -20.0% Operating Earnings – Expect a loss of about $100 million with cost reductions and continued productivity more than offset by a significant negative impact from currency, lower crop protection volumes, and the absence of prior year impacts from performance-based compensation adjustments and $36 million in gains from the sale of businesses $ in Millions 0 -250 -25.0% 3Q13 3Q14 3Q15 Margin • *See appendix for reconciliation of non-GAAP measures. 14


Слайд 15

APPENDIX 1: THIRD QUARTER 2015 SEGMENT COMMENTARY This data should be read in conjunction with the Company’s third quarter earnings news release dated October 27, 2015, DuPont’s 3Q 2015 Earnings Conference Call presentation materials and reconciliations of non-GAAP to GAAP measures included in the presentation materials and posted on the DuPont Investor Center website at www.dupont.com. 10/26/2015 15


Слайд 16

Segment Commentary Third Quarter Earnings 2015 Electronics & Communications In Electronics & Communications, operating earnings improved $14 million to $104 million, or 16 percent as cost reductions and continued productivity more than offset lower sales. Sales were 14 percent lower as volume growth in Tedlar® film in photovoltaics and consumer electronics related businesses was more than offset by the impact of competitive pressures on sales of Solamet® paste, lower metals pricing and the negative impact of currency. We expect global photovoltaic module installations will grow about 20 percent for the year driven by China, the U.S. and Japan, supporting strong demand for our Tedlar® film products. We continue to advance our Solamet® paste offering and are targeting new, higher efficiency paste offerings next year. In consumer electronics markets we are seeing a slowdown in the pace of growth, including in China. We expect fourth quarter sales to be down low-teens percent with continued solid demand for Tedlar® film more than offset by lower Solamet® paste sales and the negative impact of metals pricing and currency. Operating earnings are expected to be down mid-teens percent with cost reductions and continued productivity more than offset by the impact of lower sales. 16


Слайд 17

Segment Commentary Third Quarter Earnings 2015 Industrial Biosciences In Industrial Biosciences, sales declined 3 percent as volume gains across the business were more than offset by the impact of currency and lower prices. Volume growth in enzymes was driven by solid demand in food (primarily U.S. bakery), and home and personal care markets. Volume growth in biomaterials reflected improved demand, and improving sales in Asia Pacific as well as stabilization of U.S. channel inventories. Operating earnings of $52 million increased 24 percent on volume growth, cost reductions and continued productivity. Operating margins improved 360 basis points year over year. Excluding the impact of currency, operating earnings would have increased by 31 percent. In the fourth quarter, we anticipate continued strength in volumes, more than offset by negative currency and U.S. biomaterials prices. Sales are projected to decline by the mid-single digit percent range. We expect operating earnings up about mid-teens percent versus the prior year on operating margin expansion related to increased volume, cost reductions and continued productivity. 17


Слайд 18

Segment Commentary Third Quarter Earnings 2015 Nutrition & Health In Nutrition & Health, the business again delivered solid results and margin improvement despite significant headwinds from currency. Operating earnings increased $3 million as cost reductions and continued productivity more than offset a $17 million negative impact from currency. Excluding the impact of currency, operating earnings would have increased by about 20 percent. We delivered 160 basis points of operating margin improvement and have now grown operating margins year-over-year for nine consecutive quarters. Sales were 10 percent lower, primarily due to a 9 percent negative impact from currency. We delivered strong growth in probiotics, ingredient systems and texturants offset by lower volumes due to competitive challenges in specialty proteins. We are seeing recovery in specialty proteins with sequential growth the past two quarters. Market conditions are expected to remain challenging. In the fourth quarter, we expect continued momentum in most product lines and the specialty protein market to remain very competitive. Sales are expected to be down low-single digits percent as volume growth is more than offset by strong currency headwinds. Operating earnings are expected to be up high-single digits percent as volume growth, cost reductions and continued productivity will be partially offset by the absence of a $18 million gain on termination of a distribution agreement in the prior year and the negative impact of currency. 18


Слайд 19

Segment Commentary Third Quarter Earnings 2015 Safety & Protection Sales of $831 million declined 15 percent on a 4-percent negative impact of currency and a 4-percent negative impact from the Sontara® divestiture. Increased demand for Tyvek® protective material, including medical packaging, was more than offset by lower demand from the oil and gas industry and the military, which reduced sales of Nomex® thermal resistant fiber, Kevlar® high-strength materials, and Sustainable Solutions offerings. Third-quarter segment operating earnings of $156 million declined 20 percent, including $13 million of negative impact from currency. Cost reductions and continued productivity were more than offset by pressure from currency, volume declines, and higher costs. A slower-than-expected recovery after the 1Q Chamber Works’ outage increased unit costs in 3Q. Excluding the impact of currency, operating earnings would have decreased 13 percent. In the fourth quarter, sales are expected to be about even with prior year as volume growth will be offset by the impact of currency. Operating earnings are expected to be even with the prior year as cost reductions and continued productivity will be offset by the negative impact of currency. 19


Слайд 20

Segment Commentary Third Quarter Earnings 2015 Performance Materials Sales of $1.3 billion were down 15 percent on the negative impact of currency, lower ethylene prices and volumes, and the impact of the prior year sale of a majority interest in a joint venture. Price was down 5 percent in the quarter, with average ethylene spot prices down 60 percent year over year. Currency and portfolio together negatively impacted sales by 7 percent. Segment volume decreased 3 percent as growth in Latin America and Performance Polymers growth in North America were more than offset by lower ethylene sales and auto build weakness in Asia Pacific. Operating earnings were down 13 percent as cost reductions and continued productivity were more than offset by $47 million of negative impact from currency and lower ethylene price and volume. Excluding the impact of currency, operating earnings would have been about even with the prior year. Operating earnings included a $16 million net benefit from a joint venture, which was more than offset by the absence of a prior year $23 million gain on the sale of a majority interest in a joint venture. Global automotive market demand was up slightly in the third quarter according to IHS, which forecasted a year over year growth rate of 1 percent. Demand in Europe and North America was strong, each growing 5 percent in the quarter. China demand is now forecasted to be down 4 percent year over year versus an IHS expectation of 11 percent growth in July. In the fourth quarter, we anticipate sales will be down high-single digits percent and operating earnings down in the highteens percent as volume growth and lower product costs will be more than offset by currency and lower ethylene prices. We anticipate lower raw material costs will provide a favorable impact, partially offset by lower ethylene prices. 20


Слайд 21

Segment Commentary Third Quarter Earnings 2015 Agriculture In Agriculture, near term conditions remain challenging. Demand for seed and crop protection products, primarily in Brazil, further weakened in the quarter impacted by macroeconomic and competitive pressures. In Brazil, where the planting season is in progress, tighter farmer profit margins and credit are causing growers to be more cautious in their spending. Third quarter Agriculture sales were 30 percent lower as higher local crop protection prices in Brazil were more than offset by 17 percent lower volumes and a 15 percent negative currency impact. Seed sales were 38 percent lower and crop protection sales were down 23 percent versus last year. A weaker Real makes Brazil soybean exports more competitive globally, and this is incenting growers to plant more soybeans. In addition, soybeans require fewer inputs than corn, particularly imported fertilizer. These factors are further reducing our expectations for hybrid corn planted area and corn seed volumes in Brazil's summer season. Soybean seed volumes were lower in Brazil and in North America where adverse weather for late season planting lowered area expectations. In crop protection, we have a strong market position with high-value products like Rynaxypyr® insect control products. However, low expected insect pressure, higher inventories and the macro environment have softened the demand for insect control products. Insect control volumes were also impacted by the shutdown of the LaPorte manufacturing facility. We saw solid growth during the quarter for our picoxystrobin fungicide products in North America and Brazil. We typically report an operating loss in the third quarter as this is the lowest period during the year for agricultural sales. An operating loss of $210 million was $154 million larger as cost reductions and continued productivity, increases in local price, $27 million of gains from asset sales and a $21 million benefit related to prior periods were more than offset by lower volumes, $108 million negative currency impact and about a $40 million negative impact from the LaPorte manufacturing facility shutdown. Excluding the impact of currency, the operating loss would have been $102 million. 21


Слайд 22

Segment Commentary Third Quarter Earnings 2015 Agriculture (continued) Turning to the outlook, the fourth quarter in Agriculture is driven by the completion of the Brazil summer season and shipments to position product for the upcoming Safrinha season in Brazil and for the 2016 Northern hemisphere season. We expect strong headwinds from macroeconomic and competitive pressures to continue. For the fourth quarter we expect sales to be down low-teens percent as local pricing gains are expected to be more than offset by currency, lower crop protection volumes in Brazil and the continued impact of the shutdown of LaPorte. We expect an operating loss of about $100 million as cost reductions and continued productivity will be more than offset by a significant negative impact from currency, lower crop protection volumes, and the absence of prior year impacts from performance-based compensation adjustments and $36 million in gains from the sale of businesses. While markets remain challenging, we are confident in long-term growth in demand for agricultural products and in our pipeline of new genetics, unique trait combinations and innovative crop protection solutions coming from our focused investments in R&D. In crop protection we continue to receive registrations of Cyazypyr® insecticide in additional countries, are growing our seed treatment portfolio, and are preparing for new launches of Zorvec™ fungicide and Pyraxalt™ insecticide for rice, pending regulatory approvals. For DuPont Pioneer in Brazil we are progressing well in our limited launch of Leptra® corn hybrids for the upcoming Safrinha season with an aggressive ramp-up plan for the 2016 summer season. In North America, based upon the most recent 2015 USDA acreage estimate, we held corn market share during one of the most competitive sales seasons in recent history. Our two newest classes of genetics are showing early signs of strong harvest performance and are expected to make up about half of our North America corn sales volume in 2016. And Qrome™ corn products continue to progress well toward commercialization, having been tested this past summer in our IMPACT™ trials, as we await final import approvals in key markets. Finally, while we did lose a couple of points of North America market share in soybeans, we are very excited about what growers are experiencing this harvest season with our newest classes of T Series soybeans which we expect to represent about 80 percent of next year’s sales volume. We also have a strong portfolio of herbicide options for soybean growers including varieties tolerant to glyphosate, glufosinate, our proprietary BOLT™ technology and we are currently taking pre-orders for Roundup Ready 2 Xtend™ technology, pending regulatory approvals. Roundup® and Xtend™ are registered trademarks of Monsanto Technology LLC used under license. Dicamba herbicide is not currently approved for commercial in-crop use with soybeans with the Roundup Ready 2 Xtend™ technology and nothing herein is a promotion or an offer to sell dicamba herbicide for this use. It is a violation of federal law to promote or offer to sell unregistered pesticides or a registered pesticide for an unregistered use. 22


Слайд 23

E. I. DU PONT DE NEMOURS AND COMPANY AND CONSOLIDATED SUBSIDIARIES QUARTERLY SUPPLEMENTAL FINANCIAL DATA AND NON-GAAP RECONCILIATIONS (UNAUDITED) SEPTEMBER 30, 2015 INDEX PAGE SELECTED OPERATING RESULTS 24 SELECTED INCOME STATEMENT DATA 25 SEGMENT NET SALES 26 SEGMENT PRETAX OPERATING INCOME 27 SEGMENT OPERATING EARNINGS 28 SIGNIFICANT ITEMS BY SEGMENT - PRETAX OPERATING INCOME 29 RECONCILIATION OF NON-GAAP MEASURES RECONCILIATION OF BASE INCOME TAX RATE TO EFFECTIVE INCOME TAX RATE 30-33 34 Note: Management believes that an analysis of operating earnings (as defined on page 24), a "non-GAAP" measure, is meaningful to investors because it provides insight with respect to ongoing operating results of the company. Such measurements are not recognized in accordance with generally accepted accounting principles (GAAP) and should not be viewed as an alternative to GAAP measures of performance. The quarterly supplemental financial data and non-gaap reconciliations presents the historical financial information of DuPont restated to reflect the July 2015 spin-off of Chemours. The results of Performance Chemicals are presented as discontinued operations and have been excluded from continuing operations, segment results, and related calculations in accordance with generally accepted accounting principles in the United States (US GAAP). In addition, effective July 1, 2015, certain corporate expenses will now be included in segment operating earnings. Reclassifications of prior year data have been made to conform to current year classifications.


Слайд 24

E. I. DU PONT DE NEMOURS AND COMPANY AND CONSOLIDATED SUBSIDIARIES SELECTED OPERATING RESULTS (UNAUDITED) (dollars in millions) Year 2015 INCOME STATEMENT DATA Consolidated Net Sales Operating Earnings After Income Taxes, Attributable to DuPont (1) Significant Items - After-tax Non-Operating Pension & OPEB Costs - After-tax (2) Income from Continuing Operations After Income Taxes Attributable to DuPont Depreciation STATEMENT OF CASH FLOW DATA (3) Cash (Used for) Provided by Operating Activities Capital Expenditures (4) 3Q15 2Q15 1Q15 Year 2014 4Q14 3Q14 2Q14 1Q14 Year 2013 4Q13 3Q13 2Q13 1Q13 Year 2012 Year 2011 19,831 4,873 7,121 7,837 28,406 5,849 5,905 8,058 8,594 28,998 6,119 6,000 8,060 8,819 27,610 25,883 2,264 117 994 1,153 3,110 519 361 907 1,323 2,926 392 249 1,003 1,282 2,238 2,210 63 88 32 (57) 112 79 (9) 44 (2) (377) (292) (27) (78) 20 (657) (238) (210) (74) (57) (79) (87) (21) (22) (22) (22) (356) (80) (94) (84) (98) (437) (355) 2,117 131 969 1,017 3,135 577 330 929 1,299 2,193 20 128 841 1,204 1,144 1,617 730 241 245 244 1,006 248 247 261 250 1,027 258 254 253 262 1,065 941 (1,845) 200 78 3,712 5,514 269 350 3,179 5,512 298 36 4,849 5,152 1,350 362 378 2,062 714 544 462 1,940 674 478 449 1,890 1,910 (2,123) 610 (2,421) 342 (2,667) 339 (1) Operating earnings are defined as earnings from continuing operations (GAAP) excluding “significant items” and “non-operating pension and other post-employment benefit (OPEB) costs”. (2) First quarter 2015 includes the impact of an after-tax exchange loss on non-operating pension of $23. (3) Data is on a total company basis. (4) Includes purchases of property, plant and equipment and investment in affiliates. 3Q15 Supplemental Financial Data and Non-GAAP Reconciliations 24 10/27/2015


Слайд 25

E. I. DU PONT DE NEMOURS AND COMPANY AND CONSOLIDATED SUBSIDIARIES SELECTED INCOME STATEMENT DATA OPERATING EARNINGS (UNAUDITED) (dollars in millions, except per share) Year 2015 Consolidated Net Sales 3Q15 2Q15 1Q15 Year 2014 4Q14 3Q14 2Q14 1Q14 Year 2013 4Q13 3Q13 2Q13 1Q13 Year 2012 Year 2011 19,831 4,873 7,121 7,837 28,406 5,849 5,905 8,058 8,594 28,998 6,119 6,000 8,060 8,819 27,610 25,883 Segment Operating Earnings (1) 3,690 433 1,447 1,810 5,032 788 686 1,516 2,042 4,906 716 603 1,581 2,006 4,389 4,175 Adjusted EBIT (Operating Earnings) (1) (2) 3,385 286 1,305 1,794 4,599 806 768 1,283 1,742 4,019 441 332 1,425 1,821 3,311 3,122 Adjusted EBITDA (Operating Earnings) (1) (2) 4,421 577 1,667 2,177 5,965 1,122 1,064 1,663 2,116 5,360 766 646 1,763 2,185 4,680 4,308 Operating Earnings Before Income Taxes (1) 3,154 204 1,236 1,714 4,232 719 676 1,192 1,645 3,584 333 227 1,314 1,710 2,871 2,714 2.49 0.13 1.09 1.26 3.36 0.57 0.39 0.98 1.42 3.12 0.42 0.26 1.08 1.37 2.36 2.34 Operating Earnings Per Share (1) (3) (1) See Reconciliation of Non-GAAP Measures. (2) Adjusted EBIT from operating earnings is operating earnings (as defined on page 24) before income taxes, net income attributable to noncontrolling interests and interest expense. Adjusted EBITDA from operating earnings is adjusted EBIT from operating earnings before depreciation and amortization of intangible assets. (3) Earnings per share for the year may not equal the sum of quarterly earnings per share due to changes in average share calculations. 3Q15 Supplemental Financial Data and Non-GAAP Reconciliations 25 10/27/2015


Слайд 26

E. I. DU PONT DE NEMOURS AND COMPANY AND CONSOLIDATED SUBSIDIARIES SEGMENT NET SALES (UNAUDITED) (dollars in millions) SEGMENT NET SALES Agriculture Electronics & Communications Industrial Biosciences Nutrition & Health Performance Materials Safety & Protection Other CONSOLIDATED NET SALES Year 2015 8,248 1,577 870 2,449 4,021 2,663 3 19,831 3Q15 1,093 532 305 810 1,302 831 4,873 2Q15 1Q15 Year 2014 4Q14 3Q14 2Q14 1Q14 3,218 528 285 826 1,338 924 2 7,121 3,937 517 280 813 1,381 908 1 7,837 11,296 2,381 1,244 3,529 6,059 3,892 5 28,406 1,732 571 319 843 1,441 942 1 5,849 1,563 620 314 899 1,531 976 2 5,905 3,610 613 313 926 1,567 1,028 1 8,058 4,391 577 298 861 1,520 946 1 8,594 3Q15 Supplemental Financial Data and Non-GAAP Reconciliations 26 Year 2013 4Q13 3Q13 2Q13 1Q13 11,728 2,534 1,211 3,473 6,166 3,880 6 28,998 1,804 639 323 872 1,505 975 1 6,119 1,630 635 302 868 1,580 984 1 6,000 3,629 648 300 865 1,599 1,016 3 8,060 4,665 612 286 868 1,482 905 1 8,819 Year 2012 Year 2011 10,421 2,684 1,169 3,422 6,095 3,814 5 27,610 9,165 3,154 698 2,460 6,445 3,921 40 25,883 10/27/2015


Слайд 27

E. I. DU PONT DE NEMOURS AND COMPANY AND CONSOLIDATED SUBSIDIARIES INCOME FROM CONTINUING OPERATIONS (UNAUDITED) (dollars in millions) SEGMENT PRETAX OPERATING INCOME (LOSS) Agriculture Electronics & Communications Industrial Biosciences Nutrition & Health Performance Materials Safety & Protection Other TOTAL SEGMENT PRETAX OPERATING INCOME (1) Net Exchange Gains (Losses) (1) Non-Operating Pension & OPEBs Costs Corporate Expenses Interest Expense INCOME (LOSS) FROM CONTINUING OPERATIONS BEFORE INCOME TAXES (Provision For) Benefit From Income Taxes on Continuing Operations INCOME FROM CONTINUING OPERATIONS AFTER INCOME TAXES (1) Year 2015 3Q15 2Q15 1,878 283 147 284 933 635 (215) (63) 104 52 102 317 156 (88) 3,945 580 54 (36) (288) (115) (439) (120) (260) (82) 3,012 (886) 2,126 227 1Q15 768 1,173 100 79 44 51 96 86 299 317 301 178 (51) (76) 1,557 11 (87) (153) (94) 1,234 (96) (260) 131 974 1,808 79 (86) (166) (84) 1,551 (530) 1,021 Year 2014 4Q14 2,668 252 179 354 1,559 720 (266) 5,466 497 76 33 72 256 184 (100) 1,018 196 (128) (844) (377) 3Q14 (56) 90 42 99 366 195 (50) 686 2Q14 788 16 52 95 655 172 (58) 1,720 152 (32) (227) (87) 250 (32) (177) (93) (114) (32) (235) (94) 4,313 824 634 (1,168) (247) (303) (313) 3,145 577 331 932 1,245 1Q14 Year 2013 1,439 70 52 88 282 169 (58) 2,129 183 152 292 1,233 668 (237) (106) (41) 37 85 271 209 (70) (96) 92 41 76 357 163 (70) 2,042 4,420 385 563 (69) (123) (194) (108) (104) (140) (164) (108) (109) 47 129 84 (254) 20 131 845 (92) (32) (205) (103) 1,610 (305) 1,305 (101) (533) (772) (448) 2,566 (360) 2,206 4Q13 3Q13 2Q13 857 90 38 59 322 165 (30) 1,501 46 (124) (209) (115) 1,099 1Q13 Year 2012 Year 2011 1,474 42 36 72 283 131 (67) 1,660 200 145 256 1,036 536 (301) 1,551 420 (15) 75 992 637 132 1,971 3,532 3,792 26 (146) (205) (117) 1,529 (319) 1,210 (212) (651) (915) (464) 1,290 (122) 1,168 In the first quarter 2015, the impact of an exchange loss on non-operating pension of $23 is included within Net Exchange Gains and is excluded from Non-Operating Pension & OPEB Costs above. 3Q15 Supplemental Financial Data and Non-GAAP Reconciliations 27 10/27/2015 (213) (532) (885) (447) 1,715 (59) 1,656


Слайд 28

E. I. DU PONT DE NEMOURS AND COMPANY AND CONSOLIDATED SUBSIDIARIES OPERATING EARNINGS (UNAUDITED) (dollars in millions) SEGMENT OPERATING EARNINGS Agriculture Electronics & Communications Industrial Biosciences Nutrition & Health Performance Materials Safety & Protection Other TOTAL SEGMENT OPERATING EARNINGS Corporate Expenses Interest Expense OPERATING EARNINGS BEFORE INCOME TAXES AND EXCHANGE (LOSSES) GAINS Provision For Income Taxes on Operating Earnings, Excluding Taxes on Exchange (Losses) Gains Net After-tax Exchange (Losses) Gains (1) Less: Net Income Attr. to Noncontrolling Interests OPERATING EARNINGS Net Income Attributable to Noncontrolling Interests Non-Operating Pension & OPEB Costs - After-tax (1) Significant Items - After-tax INCOME FROM CONTINUING OPERATIONS AFTER INCOME TAXES (1) Year 2015 1,700 272 148 288 935 522 (175) 3,690 (413) (240) 3,037 (705) (59) 9 2,264 9 (210) 63 2,126 3Q15 (210) 104 52 102 317 156 (88) 433 (111) (82) 240 2Q15 1Q15 772 1,138 89 79 45 51 100 86 301 317 188 178 (48) (39) 1,447 (148) (74) 1,225 (91) (32) - (268) 42 5 117 994 (74) 88 5 (57) 32 131 974 1,810 (154) (84) 1,572 (346) (69) 4 1,153 4 (79) (57) 1,021 Year 2014 2,352 336 192 369 1,267 772 (256) 5,032 (677) (377) 3,978 (692) (166) 10 3,110 10 (87) 112 3,145 4Q14 134 92 44 79 326 205 (92) 3Q14 (56) 90 42 99 366 195 (50) 2Q14 835 84 54 103 293 203 (56) 788 686 (134) (87) (167) (93) 1,516 567 426 (13) (35) - (56) (8) 1 (279) (59) 3 519 361 907 (21) 79 1 (22) (9) 3 (22) 44 577 331 932 (174) (94) 1,248 1Q14 Year 2013 1,439 70 52 88 282 169 (58) 2,480 314 151 286 1,249 664 (238) 2,042 4,906 (202) (103) 1,737 (344) (64) 6 1,323 6 (22) (2) 1,305 (773) (448) 3,685 (680) (66) 13 2,926 13 (356) (377) 2,206 4Q13 90 90 36 79 287 205 (71) 3Q13 (56) 92 41 76 357 163 (70) 2Q13 937 90 38 59 322 165 (30) 716 603 (206) (108) (164) (108) 1,581 402 331 24 (34) - (36) (43) 3 392 249 (80) (292) 3 (94) (27) 4 (84) (78) 20 131 845 (198) (115) 1,268 (290) 29 4 1,003 1Q13 Year 2012 Year 2011 1,509 42 36 72 283 131 (67) 2,129 237 148 305 1,140 594 (164) 1,776 420 64 201 945 637 132 2,006 4,389 4,175 (205) (117) 1,684 (378) (18) 6 1,282 6 (98) 20 1,210 (842) (464) 3,083 (685) (136) 24 2,238 24 (437) (657) 1,168 (801) (447) 2,927 (544) (134) 39 2,210 39 (355) (238) 1,656 In the first quarter 2015, the impact of an after-tax exchange loss on non-operating pension of $23 is excluded from Net After-tax Exchange Losses and is included within Non-Operating Pension & OPEB Costs-After tax above. 3Q15 Supplemental Financial Data and Non-GAAP Reconciliations 28 10/27/2015


Слайд 29

E. I. DU PONT DE NEMOURS AND COMPANY AND CONSOLIDATED SUBSIDIARIES SIGNIFICANT ITEMS BY SEGMENT - PRETAX OPERATING INCOME (UNAUDITED) (dollars in millions) SEGMENT PRETAX IMPACT OF SIGNIFICANT ITEMS Agriculture Electronics & Communications Industrial Biosciences Nutrition & Health Performance Materials Safety & Protection Other Year 2015 3Q15 2Q15 1Q15 Year 2014 4Q14 3Q14 2Q14 1Q14 Year 2013 4Q13 3Q13 2Q13 1Q13 Year 2012 Year 2011 178 11 (1) (4) (2) 113 (40) 147 - (4) 11 (1) (4) (2) 113 (3) 35 (37) 316 (84) (13) (15) 292 (52) (10) 363 (16) (11) (7) (70) (21) (8) - (47) (68) (2) (8) 362 (31) (2) - (351) (131) 1 6 (16) 4 1 (196) (131) 1 6 (16) 4 1 (40) - (80) - (35) - (469) (37) (3) (49) (104) (58) (137) (225) (79) (126) 47 - 255 147 110 (2) 434 230 - 204 - (486) (331) (40) (80) (35) (857) (383) TOTAL SIGNIFICANT ITEMS BY SEGMENT - PRETAX 3Q15 Supplemental Financial Data and Non-GAAP Reconciliations 29 10/27/2015


Слайд 30

E. I. DU PONT DE NEMOURS AND COMPANY AND CONSOLIDATED SUBSIDIARIES RECONCILIATION OF NON-GAAP MEASURES (UNAUDITED) (dollars in millions, except per share) Year 2015 3Q15 2Q15 2.49 (0.23) 0.07 2.33 0.13 (0.09) 0.10 0.14 1.09 (0.07) 0.04 1.06 3,690 255 3,945 433 147 580 1,447 110 1,557 Year 2014 4Q14 3Q14 2Q14 1Q14 1.26 (0.09) (0.06) 1.11 3.36 (0.09) 0.12 3.39 0.57 (0.03) 0.09 0.63 0.39 (0.02) (0.01) 0.36 0.98 (0.03) 0.05 1.00 1.42 (0.03) 1.39 1,810 (2) 1,808 5,032 434 5,466 788 230 1,018 686 686 1,516 204 1,720 2,042 2,042 1,551 54 109 1,714 4 84 4,313 (209) 128 4,232 10 377 824 (137) 32 719 87 634 10 32 676 1 93 1,794 4,599 806 768 1Q15 Year 2013 4Q13 3Q13 2Q13 1Q13 Year 2012 Year 2011 3.12 (0.38) (0.40) 2.34 0.42 (0.09) (0.31) 0.02 0.26 (0.10) (0.03) 0.13 1.08 (0.10) (0.08) 0.90 1.37 (0.11) 0.02 1.28 2.36 (0.46) (0.70) 1.20 2.34 (0.38) (0.25) 1.71 4,906 (486) 4,420 716 (331) 385 603 1,581 2,006 (40) (80) (35) 563 1,501 1,971 4,389 (857) 3,532 4,175 (383) 3,792 1,245 1,610 (85) 3 32 32 1,192 1,645 3 6 94 103 2,566 485 533 3,584 13 448 (109) 319 123 333 108 47 40 140 227 3 108 1,099 91 124 1,314 4 115 1,529 35 146 1,710 6 117 1,290 930 651 2,871 24 464 1,715 467 532 2,714 39 447 1,283 1,742 4,019 441 332 1,425 1,821 3,311 3,122 RECONCILIATION OF DILUTED EPS (1) Operating EPS Non-Operating Pension & OPEB Costs (2) Significant Items GAAP EPS from continuing operations RECONCILIATION OF SEGMENT PTOI Segment Operating Earnings Significant Items included in Segment PTOI Segment PTOI RECONCILIATION OF ADJUSTED EBIT / ADJUSTED EBITDA TO CONSOLIDATED INCOME STATEMENTS Income From Continuing Operations Before Income Taxes Add: Significant Items - Pretax - Charge / (Benefit) Add: Non-Operating Pension & OPEB Costs - Pretax (2) Operating Earnings Before Income Taxes Less: Net Income Attributable to Noncontrolling Interests Add: Interest Expense 3,012 (169) 311 3,154 9 240 Adjusted EBIT (Operating Earnings) 3,385 286 Add: 1,036 291 362 383 1,366 316 296 380 374 1,341 325 314 338 364 1,369 1,186 4,421 577 1,667 2,177 5,965 1,122 1,064 1,663 2,116 5,360 766 646 1,763 2,185 4,680 4,308 Depreciation and Amortization Adjusted EBITDA (Operating Earnings) 227 1,234 (138) (85) 115 87 204 1,236 5 82 74 1,305 (1) Earnings per share for the year may not equal the sum of quarterly earnings per share due to changes in average share calculations. (2) First quarter 2015 includes the impact of an exchange loss on non-operating pension of $23. 3Q15 Supplemental Financial Data and Non-GAAP Reconciliations 30 10/27/2015


Слайд 31

E. I. DU PONT DE NEMOURS AND COMPANY AND CONSOLIDATED SUBSIDIARIES RECONCILIATION OF NON-GAAP MEASURES (UNAUDITED) (dollars in millions) Sep-15 Jun-15 Mar-15 Dec-14 Sep-14 Jun-14 Mar-14 Cash and Cash Equivalents Marketable Securities Total Cash 3,324 406 3,730 4,746 556 5,302 3,622 125 3,747 6,910 124 7,034 Short-Term Borrowings and Capital Lease Obligations Long-Term Borrowings and Capital Lease Obligations Total Debt 1,781 8,155 9,936 647 12,088 12,735 1,621 8,727 10,348 Net Debt (Non-GAAP) 6,206 7,433 6,601 Dec-13 Sep-13 Jun-13 Mar-13 Dec-12 Dec-11 3,982 566 4,548 4,174 173 4,347 3,782 67 3,849 8,941 145 9,086 7,005 184 7,189 6,685 211 6,896 6,555 26 6,581 4,284 123 4,407 3,586 433 4,019 1,422 9,233 10,655 3,889 9,241 13,130 2,506 9,251 11,757 2,019 9,259 11,278 1,721 10,699 12,420 4,204 10,755 14,959 3,315 10,765 14,080 2,006 11,279 13,285 1,275 10,429 11,704 817 11,691 12,508 3,621 8,582 7,410 7,429 3,334 7,770 7,184 6,704 7,297 8,489 CALCULATION OF NET DEBT Year 2015 Year 3Q15 2Q15 1Q15 2014 (2,123) 565 (2,688) 3,712 2,020 1,692 Year 4Q14 3Q14 2Q14 1Q14 2013 (2,421) 320 (2,741) 3,179 1,882 1,297 Year 4Q13 3Q13 2Q13 Year 1Q13 2012 2011 (2,667) 321 (2,988) 4,849 1,793 3,056 5,152 1,843 3,309 CALCULATION OF FREE CASH FLOW(1) Cash (Used for) Provided by Operating Activities Less: Purchases of Property, Plant and Equipment Free Cash Flow (1,845) 1,291 (3,136) 200 353 (153) 78 373 (295) 5,514 709 4,805 269 530 (261) 350 461 (111) 5,512 659 4,853 298 466 (168) 36 436 (400) (1) Data is on a total company basis. 3Q15 Supplemental Financial Data and Non-GAAP Reconciliations 31 10/27/2015


Слайд 32

E. I. DU PONT DE NEMOURS AND COMPANY AND CONSOLIDATED SUBSIDIARIES RECONCILIATION OF NON-GAAP MEASURES (UNAUDITED) Year 2015 3Q15 2Q15 1Q15 Year 2014 4Q14 3Q14 2Q14 1Q14 Year 2013 4Q13 3Q13 2Q13 1Q13 Year 2012 Year 2011 Agriculture Electronics & Communications Industrial Biosciences Nutrition & Health Performance Materials Safety & Protection 22.8% 17.9% 16.9% 11.6% 23.2% 23.8% -5.8% 19.5% 17.0% 12.6% 24.3% 18.8% 23.9% 18.9% 15.4% 11.6% 22.3% 32.6% 29.8% 15.3% 18.2% 10.6% 23.0% 19.6% 23.6% 10.6% 14.4% 10.0% 25.7% 18.5% 28.7% 13.3% 10.3% 8.5% 17.8% 19.5% -3.6% 14.5% 13.4% 11.0% 23.9% 20.0% 21.8% 2.6% 16.6% 10.3% 41.8% 16.7% 32.8% 12.1% 17.4% 10.2% 18.6% 17.9% 18.2% 7.2% 12.6% 8.4% 20.0% 17.2% -5.9% -6.4% 11.5% 9.7% 18.0% 21.4% -5.9% 14.5% 13.6% 8.8% 22.6% 16.6% 23.6% 13.9% 12.7% 6.8% 20.1% 16.2% 31.6% 6.9% 12.6% 8.3% 19.1% 14.5% 15.9% 7.5% 12.4% 7.5% 17.0% 14.1% 16.9% 13.3% -2.1% 3.0% 15.4% 16.2% TOTAL SEGMENT PTOI MARGIN % 19.9% 11.9% 21.9% 23.1% 19.2% 17.4% 11.6% 21.3% 23.8% 15.2% 6.3% 9.4% 18.6% 22.3% 12.8% 14.7% 20.6% -19.2% 17.2% 19.5% 17.0% 17.0% 11.8% 12.6% 23.3% 24.3% 19.6% 18.8% 24.0% 16.9% 15.8% 12.1% 22.5% 20.3% 20.8% 14.1% 15.4% 10.5% 20.9% 19.8% 21.1% 12.4% 12.5% 8.2% 20.3% 17.1% 5.0% 14.1% 11.1% 9.1% 19.1% 21.0% 32.3% 6.9% 12.6% 8.3% 19.1% 14.5% 20.4% 8.8% 12.7% 8.9% 18.7% 15.6% 19.4% 13.3% 9.2% 8.2% 14.7% 16.2% 18.6% 20.3% 23.1% 16.9% 11.7% 10.1% 19.6% 22.7% 15.9% 16.1% SEGMENT PTOI MARGIN % (PTOI / Segment Net Sales) (1) SEGMENT OPERATING EARNINGS MARGIN % (Operating Earnings / Segment Net Sales) (1) Agriculture Electronics & Communications Industrial Biosciences Nutrition & Health Performance Materials Safety & Protection TOTAL SEGMENT OPERATING EARNINGS MARGIN % 8.9% 28.9% 15.3% 18.2% 10.6% 23.0% 19.6% 7.7% 16.1% 13.8% 9.4% 22.6% 21.8% -3.6% 14.5% 13.4% 11.0% 23.9% 20.0% 23.1% 13.7% 17.3% 11.1% 18.7% 19.7% 32.8% 12.1% 17.4% 10.2% 18.6% 17.9% 17.7% 13.5% 11.6% 18.8% 23.8% -3.4% 14.5% 13.6% 8.8% 22.6% 16.6% 25.8% 13.9% 12.7% 6.8% 20.1% 16.2% (1) Segment PTOI / Operating Earnings margin %'s for Other (which includes the previous Pharmaceuticals segment) are not presented separately above as they are not meaningful; however, the results are included in the Total margin %'s above. 3Q15 Supplemental Financial Data and Non-GAAP Reconciliations 32 10/27/2015


Слайд 33

OPERATING EARNINGS EXCLUDING IMPACT OF CURRENCY (UNAUDITED) (dollars in millions) Reconciliation of Segment Operating Earnings excluding the impact of currency (Non-GAAP) Segment operating earnings excluding the impact of currency assumes current operating earnings results using foreign currency exchange rates in effect for the comparable prior-year period. Three months ended September 30, 2014 Agriculture Electronics & Communications Industrial Biosciences Nutrition & Health Performance Materials Safety & Protection Other Segment Operating Earnings $ (56) 90 42 99 366 195 (50) Segment Operating Earnings $ (210) 104 52 102 317 156 (88) Total Segment Operating Earnings $ $ 686 3Q15 Supplemental Financial Data and Non-GAAP Reconciliations 433 33 Three months ended September 30, 2015 Segment Operating Earnings excluding Impact of Currency currency $ (108) $ (102) 1 $ 103 (3) $ 55 (17) $ 119 (47) $ 364 (13) $ 169 $ (88) $ $ (187) $ 620 % Change -82% 14% 31% 20% -1% -13% -76% -10% 10/27/2015


Слайд 34

E. I. DU PONT DE NEMOURS AND COMPANY AND CONSOLIDATED SUBSIDIARIES RECONCILIATION OF BASE INCOME TAX RATE TO EFFECTIVE INCOME TAX RATE (UNAUDITED) Base income tax rate is defined as the effective income tax rate less the effect of exchange gains (losses), significant items and non-operating pension/OPEB costs. Three months ended September 30, 2015 2014 Effective income tax rate Significant items effect and non-operating pension/OPEB costs effect Year ended December 31, 2015 Outlook1 2014 Actual2 42.3% 0.3% 42.6% Tax rate, from continuing operations, before significant items and non-operating pension/OPEB costs Exchange gains (losses) effect3 Impact of Q4 2015 re-enactment of the U.S. tax extenders package, including the R&D tax credit Base income tax rate from continuing operations 47.8% (1.4%) 46.4% 27.0% (0.8%) 26.2% 27.1% (0.8%) 26.3% (4.7%) (33.3%) (8.9%) 37.9% 13.1% (3.2%) (1.0%) 22.0% 17.4% (1) Represents the company's anticipated full year tax rates for 2015 which includes a 1% benefit for the assumed re-enactment of the U.S. tax extenders package, including the R&D tax credit. (2) Includes impact of U.S. tax extenders which was re-enacted in Q4 2014. (3) The company does not forecast the impact of exchange gains (losses) on the projected tax rate. 3Q15 Supplemental Financial Data and Non-GAAP Reconciliations 34 10/27/2015


Слайд 35

Copyright © 2015 DuPont or its affiliates. rights reserved. Copyright © 2014 DuPont or its affiliates. All All rights reserved. The DuPont Oval Logo, DuPont™, The miracles of science™ DuPont Oval Logo, DuPont™, The miracles of science™ and all products, unless otherwise ™ or ® are registered trademarks or and all products denoted with indicated, denoted with ™ or ® are registered of E. I. du Pont de Nemours and I. du Pont de affiliates. trademarks trademarks or trademarks of E.Company or itsNemours and Company or its affiliates. Images reproduced by E. I. du Pont de Nemours and Company under +Images reproduced by Geographic Society. license from the National E. I. du Pont de Nemours and Company under license from the National Geographic Society. © National Geographic Image


Слайд 36


×

HTML:





Ссылка: